November 16, 2009 / 10:18 PM / 10 years ago

US FDA approves NeurogesX Qutenza pain patch

WASHINGTON, Nov 16 (Reuters) - The U.S. Food and Drug Administration has approved NeurogesX Inc’s NGSX.O Qutenza pain patch for shingles, the company said on Monday.

The non-narcotic patch is put directly to the site of pain and can help reduce the discomfort, often severe, for up to three months, the company said in a statement.

In June, NeurogesX Inc NGSX.O announced a distribution agreement with Japan’s Astellas Pharma Inc (4503.T) to sell Qutenza, in the European Economic Area, the Middle East and Africa. (Reporting by Maggie Fox; editing by Andre Grenon)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below